Publications and Links (79'-03')

 

1979	1980	1982	1984	1985	1986	1987	1988	1989	1990
1991	1992	1993	1994	1995	1996	1997	1998	1999	2000
2001	2002	2003

 2003

 Raulet, D.H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3:781-790.

Diefenbach, A., J.K. Hsia, M.Y. Hsiung, and D.H. Raulet. 2003. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur J Immunol 33:381-391.

Diefenbach, A., and D.H. Raulet. 2003. Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 15:37-44. 

Junqueira-Kipnis, A.P., A. Kipnis, A. Jamieson, M.G. Juarrero, A. Diefenbach, D.H. Raulet, J. Turner, and I.M. Orme. 2003. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J Immunol 171:6039-6045.

Anfossi, N., M. Lucas, A. Diefenbach, H.J. Buhring, D. Raulet, E. Tomasello, and E. Vivier. 2003. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line. Eur J Immunol 33:3514-3522.

Tajima, A., T. Tanaka, T. Ebata, K. Takeda, A. Kawasaki, J.M. Kelly, P.K. Darcy, R.E. Vance, D.H. Raulet, K. Kinoshita, K. Okumura, M.J. Smyth, and H. Yagita. 2003. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo. J Immunol 171:1715-1721. 

2002

Junqueira-Kipnis, A.P., A. Kipnis, A. Jamieson, M.G. Juarrero, A. Diefenbach, D.H. Raulet, J. Turner, and I.M. Orme. 2003. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J Immunol 171:6039-6045.

Anfossi, N., M. Lucas, A. Diefenbach, H.J. Buhring, D. Raulet, E. Tomasello, and E. Vivier. 2003. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line. Eur J Immunol 33:3514-3522.

Tajima, A., T. Tanaka, T. Ebata, K. Takeda, A. Kawasaki, J.M. Kelly, P.K. Darcy, R.E. Vance, D.H. Raulet, K. Kinoshita, K. Okumura, M.J. Smyth, and H. Yagita. 2003. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo. J Immunol 171:1715-1721. 

2002

 Chambers, C.A., J. Kang, Y. Wu, W. Held, D.H. Raulet, and J.P. Allison. 2002. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor. Blood 99:4509-4516.

Diefenbach, A., and D.H. Raulet. 2002. The innate immune response to tumors and its role in the induction of T cell immunity. Immunological Reviews 188:9-21. 

 

Diefenbach, A., E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet. 2002. Selective associations with signaling molecules determines stimulatory versus costimulatory activity of NKG2D. Nature Immunology 3:1142-1149. (Assembled with Diefenbach, A., E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet. 2004. Corrogendum: Selective association with signling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 5:658.) 

Junqueira-Kipnis, A.P., A. Kipnis, A. Jamieson, M.G. Juarrero, A. Diefenbach, D.H. Raulet, J. Turner, and I.M. Orme. 2003. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J Immunol 171:6039-6045.

Anfossi, N., M. Lucas, A. Diefenbach, H.J. Buhring, D. Raulet, E. Tomasello, and E. Vivier. 2003. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line. Eur J Immunol 33:3514-3522.

Tajima, A., T. Tanaka, T. Ebata, K. Takeda, A. Kawasaki, J.M. Kelly, P.K. Darcy, R.E. Vance, D.H. Raulet, K. Kinoshita, K. Okumura, M.J. Smyth, and H. Yagita. 2003. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo. J Immunol 171:1715-1721. 

2002

 Chambers, C.A., J. Kang, Y. Wu, W. Held, D.H. Raulet, and J.P. Allison. 2002. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor. Blood 99:4509-4516.

Diefenbach, A., and D.H. Raulet. 2002. The innate immune response to tumors and its role in the induction of T cell immunity. Immunological Reviews 188:9-21. 

 

Diefenbach, A., E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet. 2002. Selective associations with signaling molecules determines stimulatory versus costimulatory activity of NKG2D. Nature Immunology 3:1142-1149. (Assembled with Diefenbach, A., E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet. 2004. Corrogendum: Selective association with signling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 5:658.) 

Fraser, K.P., F. Gays, J.H. Robinson, K. van Beneden, G. Leclercq, R.E. Vance, D.H. Raulet, and C.G. Brooks. 2002. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2. Eur J Immunol 32:868-878. 

Hayakawa, Y., J.M. Kelly, J. Westwood, P.K. Darcy, A. Diefenbach, D.H. Raulet, and M.J. Smyth. 2002. Tumor rejection mediated by NKG2D receptor-ligand interaction is strictly dependent on perforin. J Immunol 169:5377-5381. 

Jamieson, A.M., A. Diefenbach, C.W. McMahon, N. Xiong, J.R. Carlyle, and D.H. Raulet. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17:19-29. 

Lian, R.H., M. Maeda, S. Lohwasser, M. Delcommenne, T. Nakano, R.E. Vance, D.H. Raulet, and F. Takei. 2002. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. J Immunol 168:4980-4987. 

McMahon, C.W., A.J. Zajac, A.M. Jamieson, L. Corral, G.E. Hammer, R. Ahmed, and D.H. Raulet. 2002. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. J Immunol 169:1444-1452. 

Vance, R.E., A.M. Jamieson, D. Cado, and D.H. Raulet. 2002. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation. Proc Natl Acad Sci USA 99:868-873. 

Xiong, N., C.H. Kang, and D.H. Raulet. 2002. Redundant and unique roles of two enhancer elements in the TCR gamma locus in gene regulation and gamma delta T cell development. Immunity 16:453-463. 

2001

Diefenbach, A., E.R. Jensen, A.M. Jamieson, and D.H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413:165-171. 

Diefenbach, A., and D.H. Raulet. 2001. Strategies for target cell recognition by natural killer cells. Immunol Rev 181:170-184. 

 

Hanke, T., and D.H. Raulet. 2001. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. J Immunol 166:3002-3007.

Hanke, T., H. Takizawa, and D.H. Raulet. 2001. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur J Immunol 31:3370-3379.

Kang, J., A. Volkmann, and D.H. Raulet. 2001. Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling. J Exp Med 193:689-698.

McMahon, C.W., and D.H. Raulet. 2001. Expression and function of NK cell receptors in CD8+ T cells. Curr Opin Immunol 13:465-470.

Raulet, D.H., and F. Melchers. 2001. Lymphocyte development. Curr Opin Immunol 13:163-165.

Raulet, D.H., R.E. Vance, and C.W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annual Review of Immunol sogy 19:291-330.

Tanamachi, D.M., T. Hanke, H. Takizawa, A.M. Jamieson, and D.H. Raulet. 2001. Expression of natural killer cell receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules. J Exp Med 193:307-315.

Voehringer, D., C. Blaser, P. Brawand, D.H. Raulet, T. Hanke, and H. Pircher. 2001. Viral infections induce abundant numbers of senescent CD8 T cells. J Imunol 167:4838-4843.

 2000

Coles, M.C., C.W. McMahon, H. Takizawa, and D.H. Raulet. 2000. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur J Immunol 30:236-244.

Coles, M.C., and D.H. Raulet. 2000. NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J Immunol 164:2412-2418.

Corral, L., T. Hanke, R.E. Vance, D. Cado, and D.H. Raulet. 2000. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. European Journal of Immunology 30:920-930.

Diefenbach, A., A.M. Jamieson, S.D. Liu, N. Shastri, and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunology 1:119-126. (Assembled with Diefenbach, A., E. Tomasello, M. Lucas, A.M. Jamieson, J.K. Hsia, E. Vivier, and D.H. Raulet. 2004. Corrogendum: Selective association with signling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 5:658.)

Held, W., B. Lowin-Kropf, and D.H. Raulet. 2000. Generation of short-term murine natural killer cell clones to analyze Ly49 gene expression. Methods Mol Biol 121:5-12. 

Kraft, J.R., R.E. Vance, J. Pohl, A.M. Martin, D.H. Raulet, and P.E. Jensen. 2000. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. Journal of Experimental Medicine 192:613-624.

Roth, C., J.R. Carlyle, H. Takizawa, and D.H. Raulet. 2000. Clonal acquisition of inhibitory Ly49 receptors on differentiating NK cell precursors is successively restricted and regulated by stromal cell class I MHC. Immunity 13:143-153.

 

1999

Baker, J.E., J. Kang, N. Xiong, T. Chen, D. Cado, and D.H. Raulet. 1999. A novel element upstream of the Vg2 gene in the murine T cell receptor g locus cooperates with the 3' enhancer to act as a locus control region. Journal of Experimental Medicine 190:669-679.

Corral, L., H. Takizawa, T. Hanke, A.M. Jamieson, and D.H. Raulet. 1999. A new monoclonal antibody reactive with several Ly49 NK cell receptors mediates redirected lysis of target cells. Hybridoma 18:359-366.

Diefenbach, A., and D.H. Raulet. 1999. Natural killer cells: stress out, turn on, tune in. Current Biology 9:R851-853.

Hanke, T., L. Corral, R.E. Vance, and D.H. Raulet. 1999. 2F1 antigen, the mouse homolog of the rat "mast cell function-associated antigen, is a lectin like type II transmembrane receptor expressed by natural killer cells. Eur. J. Immunol. 28:4409-4417.

Hanke, T., H. Takizawa, C.W. McMahon, D.H. Busch, E.G. Pamer, J.D. Miller, J.D. Altman, Y. Liu, D. Cado, F.A. Lemonnier, P.J. Bjorkman, and D.H. Raulet. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11:67-77.

Kang, J., M. Coles, and D.H. Raulet. 1999. Defective development of gd T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor g genes. J. Exp. Med. 190:973-982.

Raulet, D.H. 1999. Does a low level of expression of HLA molecules engender autoimmunity? New England Journal of Medicine 340:314-315.

Raulet, D.H. 1999. Development and tolerance of natural killer cells. Current Opinion in Immunology 11:129-134.

 

Vance, R.E., A.M. Jamieson, and D.H. Raulet. 1999. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. Journal of Experimental Medicine 190:1801-1812.

Zajac, A.J., R.E. Vance, W. Held, D.J.D. Sourdive, J.D. Altman, D.H. Raulet, and R. Ahmed. 1999. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J. Immunol. 163:5526-5534.

Zerrahn, J., A. Volkmann, M.C. Coles, W. Held, F.A. Lemonnier, and D.H. Raulet. 1999. Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proc Natl Acad Sci U S A 96:11470-11475.

1998

Baker, J.E., D. Cado, and D.H. Raulet. 1998. Developmentally programmed rearrangement of T cell receptor Vg genes is controlled by sequences immediately upstream of the Vg genes. Immunity 9:159-168.

Dorfman, J.R., and D.H. Raulet. 1998. Acquisition of Ly49 receptor expression by developing natural killer cells. Journal of Experimental Medicine 187:609-618.

Kang, J., M. Coles, D. Cado, and D.H. Raulet. 1998. The developmental fate of T cells is critically influenced by TCRgammadelta expression. Immunity 8:427-438.

Kang, J., H.J. Fehling, C. Laplace, M. Malissen, D. Cado, and D.H. Raulet. 1998. T cell receptor g gene regulatory sequences prevent the function of a novel TCRg/pTa pre-T cell receptor. Immunity 8:713-721.

Vance, R.E., J.R. Kraft, J.D. Altman, P.E. Jensen, and D.H. Raulet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical MHC class I molecule Qa-1b. J. Exp. Med. 188:1841-1848.

Vance, R.E., and D.H. Raulet. 1998. Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells. Current Topics in Microbiology and Immunology 230:135-160.

1997

Dorfman, J.R., J. Zerrahn, M.C. Coles, and D.H. Raulet. 1997. The basis for self-tolerance of natural killer cells in b2m- and TAP-1- mice. J. Immunol. 159:5219-5225.

Held, W., and D.H. Raulet. 1997. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in NK cell development. J. Exp. Med. 185:2079-2088.

Held, W., and D.H. Raulet. 1997. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. Eur. J. Immunol. 27:2876-2884.

Kang, J., and D.H. Raulet. 1997. Events that regulate differentiation of ab TCR+ and gd TCR+ cells from a common precursor. Seminars Immunol. 9:171-179.

Raulet, D.H., W. Held, I. Correa, J. Dorfman, M.-F. Wu, and L. Corral. 1997. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155:41-52.

Vance, R.E., D.M. Tanamachi, T. Hanke, and D.H. Raulet. 1997. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur. J. Immunol. 27:3236-3241.

Wu, M.-F., and D.H. Raulet. 1997. Class I-deficient hematopoietic cells and non-hematopoietic cells dominantly induce unresponsiveness of NK cells to class I-deficient bone marrow grafts. J. Immunol. 158:1628-1633.

Zerrahn, J., W. Held, and D.H. Raulet. 1997. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88:627-636.

1996

Dorfman, J.R., and D.H. Raulet. 1996. Major histocompatibility complex genes determine natural killer cell tolerance. Eur. J. Immunol. 26:151-155.

Held, W., D. Cado, and D.H. Raulet. 1996. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J. Exp. Med. 184:2037-2041.

Held, W., J.R. Dorfman, M.-F. Wu, and D.H. Raulet. 1996. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol. 26:2286-2292.

Raulet, D.H. 1996. Recognition events that inhibit and activate natural killer cells. Curr. Opin. Imm. 8:372-377.

1995

Correa, I., and D.H. Raulet. 1995. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2:61-71.

Held, W., J. Roland, and D.H. Raulet. 1995. Allelic exclusion of Ly49 family genes encoding class I-MHC-specific receptors on NK cells. Nature 376:355-358.

Hsiang, H.H., J.P. Goldman, and D.H. Raulet. 1995. The role of c-Myb or a related factor in regulating the T cell receptor gamma gene enhancer. J Immunol 154:5195-5204.

Kang, J., J. Baker, and D. Raulet. 1995. Evidence that productive rearrangements of TCRg genes influence the fate of developing T cells. Eur. J. Immunol. 25:2706-2709.

Raulet, D., I. Correa, L. Corral, J. Dorfman, and M.-F. Wu. 1995. Inhibitory effects of class I molecules on murine NK cells: Speculations on function, specificity and self-tolerance. Semin. Immunol. 7:103-107.

Raulet, D.H., and W. Held. 1995. Natural killer cell receptors: The offs and ons of NK cell recognition. Cell 82:697-700.

Zhang, Y., D. Cado, D.M. Asarnow, T. Komori, F.W. Alt, D.H. Raulet, and J.P. Allison. 1995. The role of short homology repeats and TdT in generation of the invariant gd antigen receptor repertoire in the fetal thymus. Immunity 3:439-447.

1994

Coles, M.C., and D.H. Raulet. 1994. Class I dependence of the development of CD4+CD8-NK1.1+ thymocytes. J. Exp. Med. 180:395-399.

Correa, I., L. Corral, and D.H. Raulet. 1994. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur. J. Immunol. 24:1323-1331.

Holsti, M., J.G. McArthur, J.P. Allison, and D.H. Raulet. 1994. The role of IL-6, IL-1 and CD28-signaling in responses of mouse CD4+ T cells to immobilized anti-TCR mAb. J. Immunol. 152:1618-1628.

Raulet, D.H. 1994. How gd T cells make a living. Curr. Biol. 4:246-248.

Raulet, D.H. 1994. MHC class I-deficient mice. Adv Immunol 55:381-421.

Raulet, D.H. 1994. Immunobiology of MHC class I-deficient mice. In Transgenesis and Targeted Mutagenesis in Immunology. H. Bluethmann and P.S. Ohashi, editors. Academic Press, San Diego. 267-29

1993

Asarnow, D.M., D. Cado, and D.H. Raulet. 1993. Selection is not required to produce invariant T cell receptor g-gene junctional sequences. Nature 362:158-160.

Bix, M., M. Coles, and D. Raulet. 1993. Positive selection of Vb8+CD4-CD8- thymocytes by class I molecules expressed by hematopoietic cells. J. Exp. Med. 178:901-908.

Davis, C., N. Killeen, M. Crooks, D. Raulet, and D. Littman. 1993. Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes. Cell 73:237-247.

Davis, C.B., N. Killeen, M.E.C. Crooks, D. Raulet, and D.R. Littman. 1993. Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes. Cell 73:237-247.

Goldman, J., D. Spencer, and D. Raulet. 1993. Ordered rearrangement of variable region genes of the T cell receptor gamma locus correlates with transcription of the unrearranged genes. Journal of Experimental Medicine 177:729-739.

Hsiang, Y.-H., D. Spencer, S. Wang, N.A. Speck, and D.H. Raulet. 1993. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-g and -d gene expression. J. Immunol. 150:3905-3916.

McArthur, J.G., and D.H. Raulet. 1993. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to IL-4. J. Exp. Med. 178:1645-1653.

1992

Bix, M., and D. Raulet. 1992. Inefficient positive selection of T-cells directed by hematopoietic cells. Nature 359:330-333.

Bix, M., and D. Raulet. 1992. Functionally conformed free class I heavy chains exist on the surface of b2-microglobulin negative cells. J Exp Med 176:829-834.

Correa, I., M. Bix, N.-S. Liao, M. Zijlstra, R. Jaenisch, and D. Raulet. 1992. Most gd T cells develop normally in b2-microglobulin-deficient mice. Proc. Natl. Acad. Sci. USA 89:653-657.

Harding, F., J. McArthur, D. Raulet, and J. Allison. 1992. CD28-mediated signalling costimulates T cell activation and prevents induction of anergy in T cell clones. Nature 356:607-609.

Liao, N.-S., and D. Raulet. 1992. Expression of the Mls-1a superantigen results in an increased frequency of Vbeta 14+ T cells. J. Immunol. 149:1151-1155.

Raulet, D. 1992. A sense of something missing (News and Views). Nature 358:21-22.

1991

Bix, M., N.-S. Liao, M. Zijlstra, J. Loring, R. Jaenisch, and D. Raulet. 1991. Rejection of class I MHC-deficient hemopoietic cells by irradiated MHC-matched mice. Nature 349:329-331.

Liao, N., M. Bix, M. Zijlstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253:199-202.

Raulet, D., D. Spencer, Y.-H. Hsiang, J. Goldman, M. Bix, N.-S. Liao, M. Zijlstra, R. Jaenisch, and I. Correa. 1991. Control of gd T cell development. Immunol. Rev. 120:185-204.

Robey, E., F. Ramsdell, J. Elliott, D. Raulet, D. Kioussis, R. Axel, and B. Fowlkes. 1991. Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex. Proc. Natl. Acad. Sci. USA 88: 608-612.

Spencer, D.M., Y.-H. Hsiang, J.P. Goldman, and D.H. Raulet. 1991. Identification of a T cell specific transcriptional enhancer located 3' of Cg1 in the murine T cell receptor g locus. Proc. Natl. Acad. Sci. USA 88:800-804.

1990

Allison, J.P., and D.H. Raulet. 1990. The immunobiology of gd+ T cells. Seminars in Immunology 2:59-65.

Liao, N.-S., J. Maltzman, and D.H. Raulet. 1990. Expression of the Vb5.1 gene by murine peripheral T cells is controlled by MHC genes an skewed to the CD8+ subset. J. Immunol. 144:In press.

Miescher, G., N.-S. Liao, L. R.K., H.R. MacDonald, and D.H. Raulet. 1990. Selective expression of Vd6 genes by B2A2- CD4-CD8- g/d thymocytes. Eur. J. Immunol. 20:41-45.

Wilson, J.M., O. Danos, M. Grossman, D.H. Raulet, and R.C. Mulligan. 1990. Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hemapoietic stem cells. Proc. Natl. Acad. Sci. USA 87:439-443.

Zijlstra, M., M. Bix, N.E. Simister, J.M. Loring, D.H. Raulet, and R. Jaenisch. 1990. b2-Microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344:742-746.

1989

Holsti, M.A., and D.H. Raulet. 1989. IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells. J. Immunol. 143:2514-2519.

Korman, A., J. Maruyama, and D.H. Raulet. 1989. Rearrangement by inversion of a T cell receptor d variable region gene located 3' of the d constant region gene. Proc. Natl. Acad. Sci. 86:267-271.

Liao, N.-S., J. Maltzman, and D.H. Raulet. 1989. Positive selection determines T cell receptor Vb14-gene usage by CD8+ T cells. J. Exp. Med. 170:135-143.

Marusic-Galesic, S., T. Saito, L. Tentori, J. Zuñiga-Pflucker, D. Raulet, J. Allison, and A. Kruisbeek. 1989. A novel gd T cell receptor for antigen adds limited diversity to the gd repertoire in adult thymus. J. Immunol. 142:28-34.

Raulet, D.H. 1989. The structure, function, and molecular genetics of the g/d T cell receptor. Annu. Rev. Immunol. 7:175-207.

Raulet, D.H. 1989. Antigens for g/d T cells. Nature 339:342-343. 

Raulet, D.H., and H.N. Eisen. 1989. The Cellular Basis of the Immune Response. In Microbiology. B. Davis, R. Dulbecco, H.N. Eisen, H.S. Ginsberg, and W.B. Wood, editors. Harper & Row Publishers, Hagerstown, MD.

1988

Korman, A., S. Marusic-Galesic, D. Spencer, A. Kruisbeek, and D.H. Raulet. 1988. Predominant variable region gene usage by g/d T cell receptor-bearing cells in the adult thymus. J. Exp. Med. 168:1021-1040.

MacDonald, H.R., R. Howe, T. Pedrazzini, R.K. Lees, R. Budd, R. Schneider, N.-S. Liao, R. Zinkernagel, J. Louis, D.H. Raulet, H. Hengartner, and G. Miescher. 1988. T cell lineages, repertoire selection and tolerance induction. Immunol. Rev. 104:157-182.

Raulet, D.H. 1988. Discussion Summary: The Gamma Chain. The T-Cell Receptor: UCLA Symposia on Molecular and Cellular Biology:111-115.

Raulet, D.H. 1988. Expression of the a, b, and g genes in T cells and thymocytes: Studies of T cell fine specificity and ontogeny. In Cytolytic Lymphocytes and Complement. E.R. Podack, editor. CRC Press, Boca Raton.

1987

Garman, R.D., K.A. Jacobs, S.C. Clark, and D.H. Raulet. 1987. B-cell-stimulatory factor 2 (b2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc. Natl. Acad. Sci. USA 84:7629-7633. 

Garman, R.D., and D.H. Raulet. 1987. Characterization of a novel murine T cell-activating factor. J Immunol. 138:1121-1129.

Lieberman, J., and D.H. Raulet. 1987. T Cell Gamma Receptor. Immunol. Res. 6:288-293.

Raulet, D.H. 1987. Tolerance, and More. Cell 49:153.

1986

Garman, R.D., P.J. Doherty, and D.H. Raulet. 1986. Diversity, rearrangement and expression of murine T cell gamma genes. Cell 45:733-742.

Garman, R.D., J.-L. Ko, C.D. Vulpe, and D.H. Raulet. 1986. T cell receptor variable region gene usage in T cell populations. Proc Natl Sci Acad USA 83:3987-3991.

Lemischka, I., D.H. Raulet, and R.C. Mulligan. 1986. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45:917-927.

Lieberman, J., C.R. Verret, D.M. Kranz, S.C. Hubbard, H. Saito, D.H. Raulet, S. Tonegawa, and H.N. Eisen. 1986. A phosphorylated, disulfide-linked membrane protein in murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 83:7870-7874.

1985

Raulet, D.H. 1985. Expression and function of interleukin-2 receptors on immature thymocytes. Nature 314:101-103.

Raulet, D.H., R.D. Garman, H. Saito, and S. Tonegawa. 1985. Developmental regulation of T-cell receptor gene expression. Nature 314:103-107.

1984

Raulet, D.H. 1984. Regulation of IL-2 production by a T cell factor. In Regulation of the Immune System. F. Sercarz, H. Cantor, and L. Chess, editors. Alan R. Liss, New York. 335-343.

1982

Klein, J.R., D.H. Raulet, M.S. Pasternack, and M.J. Bevan. 1982. Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen. J. Exp. Med. 155:1198-1203. 

Raulet, D.H., and M.J. Bevan. 1982. A differentiation factor required for the expression of cytotoxic T cell function. Nature 296:754-757.

Raulet, D.H., and M.J. Bevan. 1982. Helper T cells for cytotoxic T lymphocyte need not be I region-restricted. J. Exp. Med. 155:1766-1784.

Raulet, D.H., P. Gottleib, and M.J. Bevan. 1982. Fractionation of lymphocyte populations with monoclonal antibodies specific for Lyt-2.2 and Lyt-3.1. J. Immunol. 125:1136.

Raulet, D.H., T. Hünig, and D.C. Parker. 1982. T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants. J. Immunol. 128:908-912.

1980

Raulet, D.H., P. Gottlieb, and M.J. Bevan. 1980. Fractionation of lymphocyte population with monoclonal antibodies specific for Lyt-2.2 and Lyt-3.1. J. Immunol. 125:1136-1143.

1979 

Marshak-Rothstein, A., P. Fink, T. Gridley, D.H. Raulet, M.J. Bevan, and M.L. Gefter. 1979. Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J. Immunol. 122:2491-2497.